ERBB2 and neoplasm: OmniCAR employs a truncated SpyCatcher ectodomain paired with SpyTag-equipped antibodies or designed ankyrin repeat proteins (DARPins), demonstrating in vivo efficacy targeting CD20, Her2, EpCAM, or EGFR tumours [29,82].